Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Baxter International Inc.

NYSE

Market Cap.

17.27B

Avg. Volume

3.82M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Baxter International Inc.!

Still processing it, give me a bit more time...

Baxter International Inc. News

Baxter International Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Instruments & Supplies
baxter.com

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Baxter International Inc. Earnings & Revenue

Baxter International Inc. Financials

Table Compare

Compare BAX metrics with:

   

Earnings & Growth

BAX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

BAX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

BAX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

BAX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Baxter International Inc. Income

Baxter International Inc. Balance Sheet

Baxter International Inc. Cash Flow

Baxter International Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Baxter International Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.1600

Payment DateDividendFrequency
2024-07-010.29Quarterly
2024-04-010.29Quarterly
2024-01-020.29Quarterly
2023-10-020.29Quarterly
2023-07-030.29Quarterly

Historical Market Cap

Shares Outstanding

Baxter International Inc. Executives

NameRole
Mr. Christopher A. TothExecutive Vice President & Group President of Kidney Care
Mr. Jose E. AlmeidaChairman of the Board, President & Chief Executive Officer
Ms. Jeanne K. Mason Ph.D.?Executive Vice President & Chief Human Resources Officer
Ms. Heather KnightExecutive Vice President & Group President of Medical Products and Therapies
Mr. Alok Sonig B.E., MbaExecutive Vice President & Group President of Pharmaceuticals
NameRoleGenderDate of BirthPay
Mr. Christopher A. TothExecutive Vice President & Group President of Kidney CareMale19805.26M
Mr. Jose E. AlmeidaChairman of the Board, President & Chief Executive OfficerMale19623.62M
Ms. Jeanne K. Mason Ph.D.?Executive Vice President & Chief Human Resources OfficerFemale19561.99M
Ms. Heather KnightExecutive Vice President & Group President of Medical Products and TherapiesFemale19721.63M
Mr. Alok Sonig B.E., MbaExecutive Vice President & Group President of PharmaceuticalsMale19721.56M

Baxter International Inc. Insider Trades

Date7 May
NameWILVER PETER M
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
Date7 May
NameWilkes David S.
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
Date7 May
NameWendell Amy McBride
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
Date7 May
NameSmith Cathy R
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
Date7 May
NameShafer David Brent
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
DateNameRoleTransactionTypeShares
7 MayWILVER PETER MDirectorAcquiredA-Award5952
7 MayWilkes David S.DirectorAcquiredA-Award5952
7 MayWendell Amy McBrideDirectorAcquiredA-Award5952
7 MaySmith Cathy RDirectorAcquiredA-Award5952
7 MayShafer David BrentDirectorAcquiredA-Award5952

Discover More

Streamlined Academy

Baxter International Inc.

NYSE

Market Cap.

17.27B

Avg. Volume

3.82M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Baxter International Inc. News

Baxter International Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Baxter International Inc. Earnings & Revenue

Baxter International Inc. Income

Baxter International Inc. Balance Sheet

Baxter International Inc. Cash Flow

Baxter International Inc. Financials Over Time

Baxter International Inc. Executives

NameRole
Mr. Christopher A. TothExecutive Vice President & Group President of Kidney Care
Mr. Jose E. AlmeidaChairman of the Board, President & Chief Executive Officer
Ms. Jeanne K. Mason Ph.D.?Executive Vice President & Chief Human Resources Officer
Ms. Heather KnightExecutive Vice President & Group President of Medical Products and Therapies
Mr. Alok Sonig B.E., MbaExecutive Vice President & Group President of Pharmaceuticals
NameRoleGenderDate of BirthPay
Mr. Christopher A. TothExecutive Vice President & Group President of Kidney CareMale19805.26M
Mr. Jose E. AlmeidaChairman of the Board, President & Chief Executive OfficerMale19623.62M
Ms. Jeanne K. Mason Ph.D.?Executive Vice President & Chief Human Resources OfficerFemale19561.99M
Ms. Heather KnightExecutive Vice President & Group President of Medical Products and TherapiesFemale19721.63M
Mr. Alok Sonig B.E., MbaExecutive Vice President & Group President of PharmaceuticalsMale19721.56M

Baxter International Inc. Insider Trades

Date7 May
NameWILVER PETER M
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
Date7 May
NameWilkes David S.
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
Date7 May
NameWendell Amy McBride
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
Date7 May
NameSmith Cathy R
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
Date7 May
NameShafer David Brent
RoleDirector
TransactionAcquired
TypeA-Award
Shares5952
DateNameRoleTransactionTypeShares
7 MayWILVER PETER MDirectorAcquiredA-Award5952
7 MayWilkes David S.DirectorAcquiredA-Award5952
7 MayWendell Amy McBrideDirectorAcquiredA-Award5952
7 MaySmith Cathy RDirectorAcquiredA-Award5952
7 MayShafer David BrentDirectorAcquiredA-Award5952

Streamlined Academy

Website screenshot
HealthcareMedical - Instruments & Supplies
baxter.com

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Baxter International Inc.!

Still processing it, give me a bit more time...

Baxter International Inc. Financials

Table Compare

Compare BAX metrics with:

   

Earnings & Growth

BAX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

BAX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

BAX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

BAX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Baxter International Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.1600

Payment DateDividendFrequency
2024-07-010.29Quarterly
2024-04-010.29Quarterly
2024-01-020.29Quarterly
2023-10-020.29Quarterly
2023-07-030.29Quarterly

Baxter International Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More